S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end
S&P 500   4,967.23
DOW   37,986.40
QQQ   414.65
Biden signs bill extending a key US surveillance program after divisions nearly forced it to lapse
MarketBeat Week in Review – 4/15 - 4/19
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
Morning sickness? Prenatal check-ups? What to know about new rights for pregnant workers
A man escaped Sudan's bloody civil war. His mysterious death in Missisippi has sparked suspicion
Record Store Day celebrates indie retail music sellers as they ride vinyl's popularity wave
Panama Papers trial's public portion comes to an unexpectedly speedy end

Aesthetic Medical International Holdings Group (AIH) Competitors

$0.39
-0.02 (-4.88%)
(As of 04/19/2024 ET)

AIH vs. BACK, MIRA, ERNA, PETV, ONVO, ABVC, RDHL, AGE, BTCY, and BGLC

Should you be buying Aesthetic Medical International Holdings Group stock or one of its competitors? The main competitors of Aesthetic Medical International Holdings Group include IMAC (BACK), MIRA Pharmaceuticals (MIRA), Eterna Therapeutics (ERNA), PetVivo (PETV), Organovo (ONVO), ABVC BioPharma (ABVC), RedHill Biopharma (RDHL), AgeX Therapeutics (AGE), Biotricity (BTCY), and BioNexus Gene Lab (BGLC). These companies are all part of the "medical" sector.

Aesthetic Medical International Holdings Group vs.

IMAC (NASDAQ:BACK) and Aesthetic Medical International Holdings Group (NASDAQ:AIH) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, dividends, risk, profitability, community ranking, institutional ownership and media sentiment.

Aesthetic Medical International Holdings Group has higher revenue and earnings than IMAC.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IMAC$16.19M0.22-$18.31M-$14.04-0.22
Aesthetic Medical International Holdings Group$97.15M0.13-$11.33MN/AN/A

Aesthetic Medical International Holdings Group received 1 more outperform votes than IMAC when rated by MarketBeat users. Likewise, 33.33% of users gave Aesthetic Medical International Holdings Group an outperform vote while only 0.00% of users gave IMAC an outperform vote.

CompanyUnderperformOutperform
IMACOutperform Votes
No Votes
Underperform Votes
1
100.00%
Aesthetic Medical International Holdings GroupOutperform Votes
1
33.33%
Underperform Votes
2
66.67%

5.8% of IMAC shares are held by institutional investors. Comparatively, 2.1% of Aesthetic Medical International Holdings Group shares are held by institutional investors. 10.0% of IMAC shares are held by company insiders. Comparatively, 55.1% of Aesthetic Medical International Holdings Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IMAC
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Aesthetic Medical International Holdings Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

IMAC has a beta of 0.25, suggesting that its stock price is 75% less volatile than the S&P 500. Comparatively, Aesthetic Medical International Holdings Group has a beta of -0.03, suggesting that its stock price is 103% less volatile than the S&P 500.

In the previous week, IMAC had 70 more articles in the media than Aesthetic Medical International Holdings Group. MarketBeat recorded 71 mentions for IMAC and 1 mentions for Aesthetic Medical International Holdings Group. Aesthetic Medical International Holdings Group's average media sentiment score of 0.09 beat IMAC's score of 0.00 indicating that IMAC is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IMAC
8 Very Positive mention(s)
12 Positive mention(s)
30 Neutral mention(s)
9 Negative mention(s)
6 Very Negative mention(s)
Neutral
Aesthetic Medical International Holdings Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Aesthetic Medical International Holdings Group has a net margin of 0.00% compared to Aesthetic Medical International Holdings Group's net margin of -176.22%. IMAC's return on equity of 0.00% beat Aesthetic Medical International Holdings Group's return on equity.

Company Net Margins Return on Equity Return on Assets
IMAC-176.22% -2,069.01% -161.54%
Aesthetic Medical International Holdings Group N/A N/A N/A

Summary

Aesthetic Medical International Holdings Group beats IMAC on 8 of the 13 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AIH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AIH vs. The Competition

MetricAesthetic Medical International Holdings GroupSpecialty outpatient clinics IndustryMedical SectorNASDAQ Exchange
Market Cap$12.23M$1.63B$4.97B$7.31B
Dividend YieldN/AN/A2.93%3.99%
P/E RatioN/AN/A263.0320.02
Price / Sales0.1336.902,438.5284.35
Price / Cash1.688.0246.7934.42
Price / Book-0.651.474.554.15
Net Income-$11.33M-$13.77M$104.10M$214.00M
7 Day Performance-10.55%-3.68%-4.50%-3.52%
1 Month Performance11.78%48.80%-6.65%-5.50%
1 Year Performance-67.50%-30.15%7.74%3.52%

Aesthetic Medical International Holdings Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BACK
IMAC
0 of 5 stars
$4.54
+35.5%
N/A-27.6%$5.18M$16.19M-0.3285Gap Up
MIRA
MIRA Pharmaceuticals
0 of 5 stars
$0.79
-4.8%
N/AN/A$11.68MN/A0.002Positive News
ERNA
Eterna Therapeutics
0 of 5 stars
$2.15
flat
N/A-34.0%$11.63M$70,000.00-0.538Gap Down
PETV
PetVivo
0.7785 of 5 stars
$0.69
+11.3%
N/A-73.6%$11.57M$920,000.00-0.8025News Coverage
Positive News
ONVO
Organovo
0.4542 of 5 stars
$1.15
-14.8%
N/A-49.8%$11.55M$370,000.00-0.5318Analyst Report
High Trading Volume
ABVC
ABVC BioPharma
0 of 5 stars
$1.12
+2.8%
N/A-85.0%$11.83M$150,000.00-0.4616News Coverage
RDHL
RedHill Biopharma
0 of 5 stars
$0.38
-5.0%
N/A-85.0%$11.38M$6.53M0.00113Analyst Report
News Coverage
AGE
AgeX Therapeutics
0 of 5 stars
N/AN/AN/A$11.99M$140,000.00-0.855
BTCY
Biotricity
0.1151 of 5 stars
$1.20
-10.4%
N/AN/A$11.30M$9.64M-0.8655News Coverage
High Trading Volume
BGLC
BioNexus Gene Lab
0 of 5 stars
$0.63
+1.6%
N/AN/A$11.21M$10.93M-31.5027News Coverage
Gap Down

Related Companies and Tools

This page (NASDAQ:AIH) was last updated on 4/20/2024 by MarketBeat.com Staff

From Our Partners